Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
KLK Oleomas is a subsidiary of KLK Oleo, the oleochemical division of the Malaysian conglomerate Kuala Lumpur Kepong Berhad. The company specializes in the production of palm-based oleochemicals, including fatty acids, glycerine, and fatty esters, which serve as essential excipients and raw materials for the pharmaceutical and healthcare industries. KLK Oleomas operates advanced manufacturing facilities that are GMP-certified, ensuring the high purity and quality standards required for drug formulation and personal care products. Their products, such as pharmaceutical-grade glycerine, are used globally in various applications ranging from oral medications to topical treatments. The company is committed to sustainability, utilizing RSPO-certified palm oil and implementing green chemistry practices in its production processes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on KL-Kepong Oleomas.